[Treatment of malignant hemopathies with all transretinoic acid]

Preclinical modeling of myelodysplastic syndromes.

Leukemia·2017

Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia.

Leukemia·2016

AK2 deficiency compromises the mitochondrial energy metabolism required for differentiation of human neutrophil and lymphoid lineages.

Cell death & disease·2015

Lithium chloride antileukemic activity in acute promyelocytic leukemia is GSK-3 and MEK/ERK dependent.

Leukemia·2015

Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study.

Leukemia·2013

Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.

Oncogene·2011

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026

Artificial intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026

Artificial Intelligence in medical research and publishing: Progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026

Beyond one-size-fits-all: Personalising health communication to drive real behaviour change.

Presse medicale (Paris, France : 1983)·2026

Microneedle-mediated intelligent combination delivery for hair regeneration: A comprehensive review of technologies, mechanistic evidence, and translational prospects.

Materials today. Bio·2026

Real-world effectiveness and safety of tenofovir amibufenamide in treatment-naïve chronic hepatitis B: a 48-week retrospective cohort study.

Frontiers in medicine·2026

Impact of maintenance therapy on survival after autologous stem cell transplant for multiple myeloma regardless of response: a global analysis.

Haematologica·2026

Cutaneous Toxicities of Anti-GPRC5D Bispecific Antibodies for Multiple Myeloma: Retrospective Study.

The Journal of dermatology·2026

Development of a Recombinant Adeno-Associated Virus Vector for Human T Lymphocyte- and Natural Killer Cell-Targeted Gene Therapy.

Human gene therapy·2026

How to apply artificial intelligence (AI) to facilitate and enhance MASH trials.

Hepatology international·2026

Related Experiment Videos

[Treatment of malignant hemopathies with all transretinoic acid]

Related Concept Videos

Preclinical modeling of myelodysplastic syndromes.

Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia.

AK2 deficiency compromises the mitochondrial energy metabolism required for differentiation of human neutrophil and lymphoid lineages.

Lithium chloride antileukemic activity in acute promyelocytic leukemia is GSK-3 and MEK/ERK dependent.

Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study.

Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Artificial intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Artificial Intelligence in medical research and publishing: Progress, risks, and future perspectives.

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Beyond one-size-fits-all: Personalising health communication to drive real behaviour change.

Microneedle-mediated intelligent combination delivery for hair regeneration: A comprehensive review of technologies, mechanistic evidence, and translational prospects.

Real-world effectiveness and safety of tenofovir amibufenamide in treatment-naïve chronic hepatitis B: a 48-week retrospective cohort study.

Impact of maintenance therapy on survival after autologous stem cell transplant for multiple myeloma regardless of response: a global analysis.

Cutaneous Toxicities of Anti-GPRC5D Bispecific Antibodies for Multiple Myeloma: Retrospective Study.

Development of a Recombinant Adeno-Associated Virus Vector for Human T Lymphocyte- and Natural Killer Cell-Targeted Gene Therapy.

How to apply artificial intelligence (AI) to facilitate and enhance MASH trials.

Related Experiment Videos

[Treatment of malignant hemopathies with all transretinoic acid]

Related Concept Videos

Related Articles